Cargando…

Therapies for obsessive-compulsive disorder: Current state of the art and perspectives for approaching treatment-resistant patients

Even though obsessive compulsive disorder (OCD) is one of the ten most disabling diseases according to the WHO, only 30–40% of patients suffering from OCD seek specialized treatment. The currently available psychotherapeutic and pharmacological approaches, when properly applied, prove ineffective in...

Descripción completa

Detalles Bibliográficos
Autores principales: Swierkosz-Lenart, Kevin, Dos Santos, Joao Flores Alves, Elowe, Julien, Clair, Anne-Hélène, Bally, Julien F., Riquier, Françoise, Bloch, Jocelyne, Draganski, Bogdan, Clerc, Marie-Thérèse, Pozuelo Moyano, Beatriz, von Gunten, Armin, Mallet, Luc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978117/
https://www.ncbi.nlm.nih.gov/pubmed/36873207
http://dx.doi.org/10.3389/fpsyt.2023.1065812
_version_ 1784899444710309888
author Swierkosz-Lenart, Kevin
Dos Santos, Joao Flores Alves
Elowe, Julien
Clair, Anne-Hélène
Bally, Julien F.
Riquier, Françoise
Bloch, Jocelyne
Draganski, Bogdan
Clerc, Marie-Thérèse
Pozuelo Moyano, Beatriz
von Gunten, Armin
Mallet, Luc
author_facet Swierkosz-Lenart, Kevin
Dos Santos, Joao Flores Alves
Elowe, Julien
Clair, Anne-Hélène
Bally, Julien F.
Riquier, Françoise
Bloch, Jocelyne
Draganski, Bogdan
Clerc, Marie-Thérèse
Pozuelo Moyano, Beatriz
von Gunten, Armin
Mallet, Luc
author_sort Swierkosz-Lenart, Kevin
collection PubMed
description Even though obsessive compulsive disorder (OCD) is one of the ten most disabling diseases according to the WHO, only 30–40% of patients suffering from OCD seek specialized treatment. The currently available psychotherapeutic and pharmacological approaches, when properly applied, prove ineffective in about 10% of cases. The use of neuromodulation techniques, especially Deep Brain Stimulation, is highly promising for these clinical pictures and knowledge in this domain is constantly evolving. The aim of this paper is to provide a summary of the current knowledge about OCD treatment, while also discussing the more recent proposals for defining resistance.
format Online
Article
Text
id pubmed-9978117
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-99781172023-03-03 Therapies for obsessive-compulsive disorder: Current state of the art and perspectives for approaching treatment-resistant patients Swierkosz-Lenart, Kevin Dos Santos, Joao Flores Alves Elowe, Julien Clair, Anne-Hélène Bally, Julien F. Riquier, Françoise Bloch, Jocelyne Draganski, Bogdan Clerc, Marie-Thérèse Pozuelo Moyano, Beatriz von Gunten, Armin Mallet, Luc Front Psychiatry Psychiatry Even though obsessive compulsive disorder (OCD) is one of the ten most disabling diseases according to the WHO, only 30–40% of patients suffering from OCD seek specialized treatment. The currently available psychotherapeutic and pharmacological approaches, when properly applied, prove ineffective in about 10% of cases. The use of neuromodulation techniques, especially Deep Brain Stimulation, is highly promising for these clinical pictures and knowledge in this domain is constantly evolving. The aim of this paper is to provide a summary of the current knowledge about OCD treatment, while also discussing the more recent proposals for defining resistance. Frontiers Media S.A. 2023-02-16 /pmc/articles/PMC9978117/ /pubmed/36873207 http://dx.doi.org/10.3389/fpsyt.2023.1065812 Text en Copyright © 2023 Swierkosz-Lenart, Dos Santos, Elowe, Clair, Bally, Riquier, Bloch, Draganski, Clerc, Pozuelo Moyano, von Gunten and Mallet. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Swierkosz-Lenart, Kevin
Dos Santos, Joao Flores Alves
Elowe, Julien
Clair, Anne-Hélène
Bally, Julien F.
Riquier, Françoise
Bloch, Jocelyne
Draganski, Bogdan
Clerc, Marie-Thérèse
Pozuelo Moyano, Beatriz
von Gunten, Armin
Mallet, Luc
Therapies for obsessive-compulsive disorder: Current state of the art and perspectives for approaching treatment-resistant patients
title Therapies for obsessive-compulsive disorder: Current state of the art and perspectives for approaching treatment-resistant patients
title_full Therapies for obsessive-compulsive disorder: Current state of the art and perspectives for approaching treatment-resistant patients
title_fullStr Therapies for obsessive-compulsive disorder: Current state of the art and perspectives for approaching treatment-resistant patients
title_full_unstemmed Therapies for obsessive-compulsive disorder: Current state of the art and perspectives for approaching treatment-resistant patients
title_short Therapies for obsessive-compulsive disorder: Current state of the art and perspectives for approaching treatment-resistant patients
title_sort therapies for obsessive-compulsive disorder: current state of the art and perspectives for approaching treatment-resistant patients
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978117/
https://www.ncbi.nlm.nih.gov/pubmed/36873207
http://dx.doi.org/10.3389/fpsyt.2023.1065812
work_keys_str_mv AT swierkoszlenartkevin therapiesforobsessivecompulsivedisordercurrentstateoftheartandperspectivesforapproachingtreatmentresistantpatients
AT dossantosjoaofloresalves therapiesforobsessivecompulsivedisordercurrentstateoftheartandperspectivesforapproachingtreatmentresistantpatients
AT elowejulien therapiesforobsessivecompulsivedisordercurrentstateoftheartandperspectivesforapproachingtreatmentresistantpatients
AT clairannehelene therapiesforobsessivecompulsivedisordercurrentstateoftheartandperspectivesforapproachingtreatmentresistantpatients
AT ballyjulienf therapiesforobsessivecompulsivedisordercurrentstateoftheartandperspectivesforapproachingtreatmentresistantpatients
AT riquierfrancoise therapiesforobsessivecompulsivedisordercurrentstateoftheartandperspectivesforapproachingtreatmentresistantpatients
AT blochjocelyne therapiesforobsessivecompulsivedisordercurrentstateoftheartandperspectivesforapproachingtreatmentresistantpatients
AT draganskibogdan therapiesforobsessivecompulsivedisordercurrentstateoftheartandperspectivesforapproachingtreatmentresistantpatients
AT clercmarietherese therapiesforobsessivecompulsivedisordercurrentstateoftheartandperspectivesforapproachingtreatmentresistantpatients
AT pozuelomoyanobeatriz therapiesforobsessivecompulsivedisordercurrentstateoftheartandperspectivesforapproachingtreatmentresistantpatients
AT vonguntenarmin therapiesforobsessivecompulsivedisordercurrentstateoftheartandperspectivesforapproachingtreatmentresistantpatients
AT malletluc therapiesforobsessivecompulsivedisordercurrentstateoftheartandperspectivesforapproachingtreatmentresistantpatients